Reuters logo
BRIEF-Female Health Co initiates bioequivalence clinical trial
March 9, 2017 / 2:06 PM / 9 months ago

BRIEF-Female Health Co initiates bioequivalence clinical trial

March 9 (Reuters) - Female Health Co:

* The Female Health Company / Veru Healthcare initiates bioequivalence clinical trial comparing tamsulosin drs with flomax®

* Female Health Co - expected nda approval would be sometime in mid to late 2018

* Goal is to have stage 1 clinical trial results completed by april 2017

* Female Health - stability data is being collected for commercial manufactured drug batches to allow an anticipated nda filing late 2017 / early 2018

* Female Health -initiated stage 1 of bioequivalence clinical trial designed to select optimal formulation of proprietary tamsulosin delayed release sachet product Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below